Innovative combination of lactic acid and protein for the treatment of muscular atrophy and skeletal diseases

摘要

This description describes a new actriib-ecd hybrid polypeptide.This note provides methods for the treatment or prevention of muscle atrophy, skeletal diseases, metabolic diseases, fibrosis, autoimmune/inflammatory diseases.Cardiovascular disease, cancer or cancer, chronic kidney disease, arthritis, anorexia, liver disease, refusal to transplant organs or tissues, anemia,People in need are suffering and/or aging.In addition, this note provides a method for inducing stem cell growth to repair tissue or organ regeneration in an object.The above methods include effective treatment of patients and ligation of the polypeptide Trap with mixed Actriib.This description also provides drug synthesis including a mixture of ACtriib ligament polypeptide Trap.